{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T06:54:44Z","timestamp":1763016884867},"reference-count":23,"publisher":"American Society for Microbiology","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>We have very limited information on serum neutralizing antibody in women naturally infected with the human papillomaviruses (HPVs) that are causally associated with cervical cancer. In this study, serum samples collected from 217 Japanese women with low-grade cervical intraepithelial neoplasia were examined for their neutralizing activities against HPV16, -18, -31, -52, and -58 pseudovirions. Eighty-four patients (39%), 35 patients (16%), 17 patients (8%), and 1 patient were positive for neutralizing antibodies against one, two, three, and four of these types, respectively. Presence of neutralizing antibody did not always correlate with detection of HPV DNA in cervical swabs collected at the time of blood collection. The neutralizing titers of the majority of sera, ranging between 40 and 640, were found to be conserved in the second sera, collected 24 months later, independently of emergence of HPV DNA in the second cervical swabs. The data strongly suggest that HPV infection induces anti-HPV neutralizing antibody at low levels, which are maintained for a long period of time.<\/jats:p>","DOI":"10.1128\/cvi.00197-08","type":"journal-article","created":{"date-parts":[[2008,8,28]],"date-time":"2008-08-28T00:54:20Z","timestamp":1219884860000},"page":"1536-1540","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":13,"title":["Neutralizing Antibodies against Human Papillomavirus Types 16, 18, 31, 52, and 58 in Serum Samples from Women in Japan with Low-Grade Cervical Intraepithelial Neoplasia"],"prefix":"10.1128","volume":"15","author":[{"given":"Hiroyuki","family":"Ochi","sequence":"first","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Kondo","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Oki","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Yasugi","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Furuta","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hirai","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahito","family":"Kanda","sequence":"additional","affiliation":[{"name":"Center for Pathogen Genomics, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan"},{"name":"Department of Obstetrics and Gynecology, Graduate School of Comprehensive Human Science, University of Tsukuba, 1-1-1 Tennodai, Tsukuba City, Ibaraki 305-8575, Japan"},{"name":"Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan"},{"name":"Department of Pathology, Cancer Institute"},{"name":"Departments of Gynecology and Cytopathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.751-757.2004"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02726-07"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1097-2765(00)80449-9","volume":"5","year":"2000","unstructured":"Chen, X. S., R. L. Garcea, I. Goldberg, G. Casini, and S. C. Harrison. 2000. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell5:557-567.","journal-title":"Mol. Cell"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","year":"2004","unstructured":"de Villiers, E. M., C. Fauquet, T. R. Broker, H. U. Bernard, and H. zur Hausen. 2004. Classification of papillomaviruses. Virology324:17-27.","journal-title":"Virology"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1042\/CS20050369","volume":"110","year":"2006","unstructured":"Doorbar, J. 2006. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci.110:525-541.","journal-title":"Clin. Sci."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1016\/j.vaccine.2006.06.005","volume":"24","year":"2006","unstructured":"Giannini, S. L., E. Hanon, P. Moris, M. Van Mechelen, S. Morel, F. Dessy, M. A. Fourneau, B. Colau, J. Suzich, G. Losonksy, M. T. Martin, G. Dubin, and M. A. Wettendorf. 2006. Enhanced humoral and memory B cellular using HPV16\/18 L1 VLP vaccine formulated with the MPL\/aluminium salt combination (AS04) compared to aluminium salt only. Vaccine24:5937-5949.","journal-title":"Vaccine"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0264-410X(00)00370-4","volume":"19","year":"2001","unstructured":"Giroglou, T., M. Sapp, C. Lane, C. Fligge, N. D. Christensen, R. E. Streeck, and R. C. Rose. 2001. Immunological analyses of human papillomavirus capsids. Vaccine19:1783-1793.","journal-title":"Vaccine"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","volume":"367","year":"2006","unstructured":"Harper, D. M., E. L. Franco, C. M. Wheeler, A. B. Moscicki, B. Romanowski, C. M. Roteli-Martins, D. Jenkins, A. Schuind, S. A. Costa Clemens, G. Dubin, et al. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papilomavirus types 16 and 18: follow-up from a randomized control trial. Lancet367:1247-1255.","journal-title":"Lancet"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","volume":"89","year":"1992","unstructured":"Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA89:12180-12184.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.virol.2006.08.037","volume":"358","year":"2007","unstructured":"Kondo, K., Y. Ishii, H. Ochi, T. Matsumoto, H. Yoshikawa, and T. Kanda. 2007. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology358:266-272.","journal-title":"Virology"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/jmv.21124","volume":"80","year":"2008","unstructured":"Kondo, K., H. Ochi, T. Matsumoto, H. Yoshikawa, and T. Kanda. 2008. Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes. J. Med. Virol.80:841-846.","journal-title":"J. Med. Virol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","volume":"347","year":"2002","unstructured":"Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, and K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med.347:1645-1651.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10647440400028151","volume":"13","year":"2005","unstructured":"Maehama, T. 2005. Epidemiological study in Okinawa, Japan, of human papillomavirus infection of the uterin cervix. Infect. Dis. Obstet. Gynecol.13:77-80.","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1099\/vir.0.83458-0","volume":"89","year":"2008","unstructured":"Mbulawa, Z. Z., A. L. Williamson, D. Stewart, J. A. Passmore, L. Denny, B. Allan, and D. J. Marais. 2008. Association of serum and mucosal neutralizing antibodies to human papillomavirus type 16 (HPV-16) with HPV-16 infection and cervical disease. J. Gen. Virol.89:910-914.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","volume":"111","year":"2004","unstructured":"Mu\u00f1oz, N., F. X. Bosch, X. Castellsague, M. Diaz, S. Sanjose, D. Hammouda, K. V. Shah, and C. J. L. M. Meijer. 2004. Against which human papillomavirus types shall we vaccinate and screen? Int. J. Cancer111:278-285.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2003.12.027","volume":"321","year":"2004","unstructured":"Pastrana, D. V., C. B. Buck, Y. Y. Pang, C. D. Thompson, P. E. Castle, D. C. FitzGerald, S. Kruger Kjaer, D. R. Lowy, and J. T. Schiller. 2004. Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18. Virology321:205-216.","journal-title":"Virology"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ijc.1571","volume":"97","year":"2002","unstructured":"Pisani, P., F. Bray, and M. Parkin. 2002. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int. J. Cancer97:72-81.","journal-title":"Int. J. Cancer"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61416-0"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4161\/hv.3.4.4058","volume":"3","year":"2007","unstructured":"Smith, J. F., M. Brownlow, M. Brown, R. Kowalski, M. T. Esser, W. Ruiz, E. Barr, D. R. Brown, and J. T. Bryan. 2007. Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions. Hum. Vaccin.3:109-115.","journal-title":"Hum. Vaccin."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00013-08"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","year":"2005","unstructured":"Villa, L. L., R. L. Costa, C. A. Petta, R. P. Andrade, K. A. Alut, A. R. Giuliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, F. F. Skjeldestad, S. E. Olsson, M. Steinwall, D. R. Brown, R. J. Kurman, B. M. Ronnett, M. H. Stoler, A. Frenczy, D. M. Harper, G. M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F. J. Taddeo, K. U. Jansen, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol.6:271-278.","journal-title":"Lancet Oncol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.olq.0000240315.19652.59","volume":"34","year":"2007","unstructured":"Winer, R. L., Q. Feng, J. P. Hughes, M. Yu, N. B. Kiviat, S. O'Reilly, and L. A. Koutsky. 2007. Concordance of self-collected and clinician-collected swab samples for detecting human papillomavirus DNA in women 18 to 32 years of age. Sex. Transm. Dis.34:371-377.","journal-title":"Sex. Transm. Dis."},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1349-7006.1991.tb01882.x","volume":"82","year":"1991","unstructured":"Yoshikawa, H., T. Kawana, K. Kitagawa, M. Mizuno, H. Yoshikura, and A. Iwamoto. 1991. Detection and typing of multiple genital papillomaviruses by DNA amplification with consensus primers. Jpn. J. Cancer Res.82:524-531.","journal-title":"Jpn. J. Cancer Res."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00197-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00197-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T20:39:33Z","timestamp":1627591173000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00197-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1128\/CVI.00197-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00197-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"2008-05-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-08-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}